Prosecution Insights
Last updated: November 16, 2026
Application No. 17/981,362

AI-enhanced Wearable Photo-Electro-Tonoarteriography (PETAG) Method And Apparatus

Final Rejection §101§112
Filed
Nov 04, 2022
Priority
Jun 21, 2022 — CN 202210706973.1
Examiner
FEDORKY, MEGAN TAYLOR
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited
OA Round
4 (Final)
31%
Grant Probability
At Risk
5-6
OA Rounds
67%
With Interview

Examiner Intelligence

Grants only 31% of cases
31%
Career Allowance Rate
12 granted / 39 resolved
-39.2% vs TC avg
Strong +36% interview lift
Without
With
+35.9%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
35 currently pending
Career history
90
Total Applications
across all art units

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's amendments filed 14MAY2026 regarding the rejections under 35 USC 112(a) have been fully considered and have been found to obviate the rejections. Therefore, the 112(a) rejections have been withdrawn. The term “multimodal model-based multi-task learning network” has been removed by the applicant to address the new matter rejection applied to claims 1 & 10 (7 being canceled). The amended functional language “determine/determining a signal processing result related to tonoarteriography (TAG) information and/or related to cardiac disease information” contains a new grounds for rejection based on it’s reliance to the previously rejected term “multimodal model-based multi-task learning network”. See below. Applicant's amendments filed 14MAY2026 regarding the rejections under 35 USC 112(b) have been fully considered and have been found to obviate the rejections. Therefore, the 112(a) rejections have been withdrawn. Applicant's amendments filed 14MAY2026 regarding the interpretations under 35 USC 112(f) have been fully considered and have been found to obviate the rejections. Therefore, the 112(f) interpretations have been withdrawn. Applicant's amendments and arguments filed 14MAY2026 regarding the rejections under 35 USC 101 have been fully considered and have been found to be not persuasive. Parts deemed not persuasive discussed below: Regarding Step 2A, Prong One, Applicant states (see Pages 8-9 of the Remarks): Firstly, the claims as currently amended are not directed to a mental process. Particularly, independent claims 1 and 10 have now been amended to require, among other things: collecting physiological signals from electrically conductive clothing worn by a target subject, using a specific ECG electrode and plurality of MWPPG sensors, iteratively filtering noise using impedance information associated with a chest V1 lead and a limb lead II, generating a new noise-reduced signal for repeated iteration, converting the signal to obtain additional, different leads, and determining a signal processing result from the resulting physiological signals. It is readily understandable that these operations are not practically performable in the human mind or by pen and paper. A human cannot mentally collect synchronized ECG and MWPPG signals from the claimed wearable sensor arrangement, iteratively remove noise using the claimed impedance-reference scheme, and convert those signals into additional leads in the manner required by the claims. It appears that the Examiner's analysis in the latest office action has isolated the "outputting, via a communication module, a signal processing result related to a tonoarteriography (TAG information and/or related to a cardiac disease information" aspect as a mental process. However, eligibility must be evaluated on the claim as a whole, not by ignoring the other technological context. The amended independent claims, when considered as a whole, require a specific wearable sensing arrangement (electrically conductive clothing with an ECG electrode and MWPPG sensors) and an iterative adaptive filtering technique that uses impedance information associated with specific lead configurations (chest V1 and limb lead II) to generate noise-reduced signals and convert those signals to obtain additional leads. These are technological operations tied to physical sensors and physiological signals. They are not practically performed in the human mind or with pen and paper, particularly in view of the iterative adaptive filtering and lead conversion steps applied to acquired ECG/MWPPG signals from the wearable garment platform. However, the examiner is not persuaded as the claim limitations as currently written require using the data acquisition steps to obtain at least one of each physiological signal to perform the following steps. A clinician could readily record raw sensor data that is being generated from a patients wearable sensing garment, especially when only required by the steps to need one set of data to start. The data processing steps amounts to only filtering the data for noise iteratively. These steps are combining data points removing noise, and using the resulting value as a reference for new acquired data processing until one can “determine a signal processing result related to tonoarteriography (TAG) information and/or related to cardiac disease information” (Claim 1 Lines 14-15). A clinician would be readily able to perform noise filtering to use the combine data as a new noise reference for further data as the tasks of combining data information as well as noise filtering do not require automation to perform. One would merely need to know what data thresholds are necessary to determine what signals are noise. Further, the claim does not contain any limitations that could be considered non abstract in a manner that one could recreate the invention with reproducible results because the claims do not even state the signal processing results being accomplished. Therefore, the examiner maintains that the claims are patent ineligible. Regarding Step 2A Prong Two, Applicant states (see Page 10 of the Remarks): Even if the Examiner were to regard portions of the adaptive filtering or signal processing as involving mathematical operations, the claims do not seek to monopolize those operations in the abstract. Rather, the invention requires those operations in a specific technological context to improve physiological signal acquisition and processing in a wearable PETAG system. For example, independent claims 1 and 10 recite a concrete technological application: a specific wearable sensing platform, specific physiological inputs, a particular iterative filtering framework using lead- associated impedance information, signal conversion to additional leads, and generation of clinically useful PETAG/TAG and cardiac- related outputs. The independent claims direct to a specific signal-acquisition and signal-processing technique for wearable cardiac monitoring. Such claims are patent-eligible where they improve the functioning of a technological system or provide a concrete improvement in processing measured data. Thus, any alleged judicial exception is integrated into a practical application, and the claims are not directed to an abstract idea. However, the argument is not persuasive because the claims fails to distinctly claim a technological solution and only list general data processing. The claims use known sensors (MWPPG/ECG sensors) attached to clothing, data processing in the form of filtering for noise and combining impedance values in an iterative process, and the system outputs a result. The claims lack and practical application such as showing how the system uses novel components/configurations or how the data processing is an inventive concept such as by showing the processing steps. Further, the claims lack any specificity in the processing steps such that one would understand how to filter the data, combine the data, or what signal processing is being performed to achieve a result. Therefore, the examiner maintains that the claims are patent ineligible. Regarding Step 2B, Applicant states (see Pages 10-11 of the Remarks): The independent claims recite significantly more than any alleged exception. The ordered combination of: conductive clothing carrying the recited sensors, acquisition of ECG and MWPPG signals from that clothing, iterative filtering using the particular impedance- reference scheme tied to the recited leads, conversion to additional leads, and processor-based determination and communication of PETAG/TAG and cardiac-related results is not shown by the art of record as routine and conventional. Indeed, the Examiner has already withdrawn the prior-art rejections and expressly stated that the prior art of record does not disclose or suggest the claimed iterative impedance- based processing from data collected by sensors disposed on a wearable garment using the recited lead arrangement. This finding strongly undercuts any suggestion that the recited ordered combination is merely conventional. However, the argument is not persuasive. Lack of novelty under 35 U.S.C. 102 or obviousness under 35 U.S.C. 103 of a claimed invention does not necessarily indicate that additional elements are well-understood, routine, conventional elements. Because they are separate and distinct requirements from eligibility, patentability of the claimed invention under 35 U.S.C. 102 and 103 with respect to the prior art is neither required for, nor a guarantee of, patent eligibility under 35 U.S.C. 101. The distinction between eligibility (under 35 U.S.C. 101 ) and patentability over the art (under 35 U.S.C. 102 and/or 103 ) is further discussed in MPEP § 2106.05(d). Therefore, the examiner maintains that the claims are not patent eligible. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-4 & 9-11 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Regarding Claims 1 & 10: The claim recites “determine/determining a signal processing result related to tonoarteriography (TAG) information and/or related to cardiac disease information” in lines 26-28 & 31-33 respectively. The specification provides only intended functional results with no details on how the processing result is determined or calculated other than by using the multimodal network. There is no clear indication how the model is actually constructed to produce the specifically claimed results. Under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph as lacking adequate written description because the specification does not describe the claimed invention in sufficient detail that one skilled in the art can reasonably conclude that the inventor had possession of the claimed invention. As an example, if the means- (or step-) plus-function limitation is computer-implemented, and the specification does not provide a disclosure of the algorithm in sufficient detail to demonstrate to one of ordinary skill in the art that the inventor possessed the invention , see MPEP § 2161.01. See Specification paragraph: [0015] In a possible embodiment, wherein the step of processing the ECG signal and the multi-wavelength signal by a multimodal model-based multi-task learning network, determining a signal processing result related to a TAG information and/or related to a cardiac disease information, comprising: performing feature extraction on the ECG signal and the MWPPG signals through frequency domain attention based neural network and time domain interpretative based neural network to obtain a first feature information; performing feature extraction on the MWPPG signals to obtain a second feature information; performing pooling operation on the first feature information; performing feature fusion classification process against the second feature information and the pooled first feature information to determine the signal processing result related to the TAG information and/or related to the cardiac disease information. As well as paragraphs: [0009]; [0018]; [0024]; [0038]; 90064]; [0069]; [0075]; [0081]; & [0086] Claims 2-4, 9, & 11 are additionally rejected for depending upon the rejected claim(s). The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1, 2-4, & 9-11 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding Claims 1 & 10: The claim recites “The claim recites “determine/determining a signal processing result related to tonoarteriography (TAG) information and/or related to cardiac disease information” in lines 26-28 & 31-33 respectively. This is unclear what the signal processing result is intended to be as the specification does not indicate a specific treatment or function to be run by the multimodal learning network. See Specification paragraph for example: [0015] In a possible embodiment, wherein the step of processing the ECG signal and the multi-wavelength signal by a multimodal model-based multi-task learning network, determining a signal processing result related to a TAG information and/or related to a cardiac disease information, comprising: performing feature extraction on the ECG signal and the MWPPG signals through frequency domain attention based neural network and time domain interpretative based neural network to obtain a first feature information; performing feature extraction on the MWPPG signals to obtain a second feature information; performing pooling operation on the first feature information; performing feature fusion classification process against the second feature information and the pooled first feature information to determine the signal processing result related to the TAG information and/or related to the cardiac disease information. [0016] In a possible embodiment, wherein the signal processing result related to the TAG information comprises at least one of a TAG signal, a systolic blood pressure information, a diastolic blood pressure information, a blood pressure variation (BPV) information and a hypertension information; the signal processing result related to the cardiac disease information comprises at least one of an electrocardiogram, an arrhythmia detection result and a myocardial infarction detection result. The provided disclosures of the determination do not provide sufficient information regarding the determination process to arrive at a claimed result of detecting arrythmia, myocardial infarctions, or any other TAG/cardiac result. For the purpose of examination, the examiner is interpreting this as the detection of arrhythmias. Appropriate correction is required. Claims 2-4, 9, & 11 are additionally rejected for depending upon the rejected claim 1. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-4, & 9-11 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Step 1 The claims recite: Claim 1 is to a method. Claim 10 is to an apparatus. Therefore, claims 1-4, & 9-11 are directed to a statutory category of invention. Step 2A, Prong One Regarding claims 1 & 10 the limitation of “outputting by transmitting the signal processing result to a user apparatus and/or to a cloud database and/or a medical platform” is a mental process. The limitations as drafted, covers performance of the limitations that can be performed by a human using a pen and paper under the broadest reasonable interpretation standard. For example, determining a result related to a TAG information and/or related to a cardiac disease information encompasses nothing more than a user tracking data collected from a sensor on paper and determining if the data surpasses a threshold to consider it a disease marker. Outputting can be simply interpreted as a person entering the results into a database by hand. If claim limitation, under its broadest reasonable interpretation, covers performance of the limitation in human mind or by a human using a pen and paper, then it falls within the “Mental Processes” grouping of abstract ideas. See MPEP 2106.04(a)(2)(III). The presence of mathematical algorithms and concepts, particularly “processing, via the one or more processors the obtained noise reduced electrocardiogram signal and the MWPPG signals”, “converting the noise reduced signal to obtain a noise reduced signal of the one or more additional, different, leads”, and “iteratively perform the following operations until a stop iteration condition is met: combining impedance information between an electrode of a left arm and a right arm, and between electrode of a right arm and a left leg to form a combined impedance information; filtering noise from the electrocardiogram signal and the MWPPG signals, and generating a new noise reduced signal; and using the noise reduced signal and the impedance information as input data for a next iteration; are also considered a judicial exception as mathematical concepts are considered laws of nature per MPEP 2106.04(a)(2)(II). Step 2A, Prong Two This judicial exception is not integrated into a practical application. In particular, the claims recite additional elements of “an electrocardiogram electrode acquiring at least one lead electrocardiogram signal and MWPPG signals”; “acquiring via a plurality of multi-wavelength photoplethysmography sensors, multi-wavelength photoplethysmogram (MWPPG) signals.”; “filtering, via an adaptive filter, noise from the electrocardiogram signal to obtain a noise reduced signal” and “wherein the acquiring step comprises collecting the at least one lead electrocardiogram signal and the MWPPG signals from an electrically conductive clothing worn by the target subject” is related to data gathering and processing; and “one or more processors for processing the electrocardiogram signal and the MWPPG signals to determine a signal processing result related to tonoarteriography (TAG) information and/or related to cardiac disease information” which is related to a generic computer implementation by a processor. Accordingly, this additional element does not integrate the abstract idea into a practical application because it does not impose any meaningful limits on practicing the abstract idea. The claim is directed to an abstract idea. Step 2B The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional elements “an electrocardiogram electrode acquiring at least one lead electrocardiogram signal and MWPPG signals”; “acquiring via a plurality of multi-wavelength photoplethysmography sensors, multi-wavelength photoplethysmogram (MWPPG) signals.”; “filtering, via an adaptive filter, noise from the electrocardiogram signal to obtain a noise reduced signal” and “wherein the acquiring step comprises collecting the at least one lead electrocardiogram signal and the MWPPG signals from an electrically conductive clothing worn by the target subject” is related to data gathering and processing; and “one or more processors for processing the electrocardiogram signal and the MWPPG signals to determine a signal processing result related to tonoarteriography (TAG) information and/or related to cardiac disease information” which is related to a generic computer implementation by a processor. Therefore, the claims are not patent eligible. Regarding the dependent claims 2-4, 9, & 11, the claims recite data gathering (claims 2-4), further introducing generic components/concepts (claim 11), and insignificant pre-solution activity (claims 9, & 11), and does no more to further limit the physical means for acquiring data outside of the electric conductive clothing worn by the target subject, electrocardiogram electrode, multi-wavelength photoplethysmography sensors, various types of garments the device may be implemented on, a “user apparatus which comprises at least one of a mobile phone, a watch and glasses”, a sensing module, and communication module, but these items are generic to the field and do not provide novelty or distinct structure to the claimed invention. Therefore, claims 1-4, & 9-11 are directed to an abstract idea without significantly more. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Megan Fedorky whose telephone number is 571-272-2117. The examiner can normally be reached Mon-Fri 3PM-11PM ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached on Mon-Fri 9AM-5PM ET. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MEGAN T FEDORKY/ Examiner, Art Unit 3796 /Jennifer Pitrak McDonald/Supervisory Patent Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Show 1 earlier event
Mar 26, 2025
Non-Final Rejection mailed — §101, §112
Jun 10, 2025
Response Filed
Sep 18, 2025
Final Rejection mailed — §101, §112
Dec 10, 2025
Request for Continued Examination
Dec 19, 2025
Response after Non-Final Action
Feb 26, 2026
Non-Final Rejection mailed — §101, §112
May 14, 2026
Response Filed
Aug 21, 2026
Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12527959
Compliance Voltage Monitoring and Adjustment in an Implantable Medical Device Using Low Side Sensing
4y 3m to grant Granted Jan 20, 2026
Patent 12396787
CATHETER WITH INTEGRATED THIN-FILM MICROSENSORS
4y 8m to grant Granted Aug 26, 2025
Patent 12376904
DYNAMIC LASER STABILIZATION AND CALIBRATION SYSTEM
3y 11m to grant Granted Aug 05, 2025
Patent 12350026
PHOTOPLETHYSMOGRAPHY SENSOR AND SEMICONDUCTOR DEVICE INCLUDING THE SAME
4y 4m to grant Granted Jul 08, 2025
Patent 12295647
HIGH DENSITY MAPPING CATHETER FOR CRYOBALOON ABLATION
4y 6m to grant Granted May 13, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
31%
Grant Probability
67%
With Interview (+35.9%)
High
PTA Risk
Based on 39 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month